Hepatopathy following irradiation and adriamycin

Larry E. Kun, Bruce M. Camitta

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

This report describes two cases of hepatopathy following irradiation and adriamycin at doses and volumes of irradiation ordinarily considered within the tolerance of hepatic function. In one case fatal hepatopathy followed 2400 rad/17 fractions/28 days to the entire liver with preceding and concurrent adriamycin. In the second case moderate clinical changes occurred after treatment in which much of the right lobe of the liver was shielded following 2500 rad/23 fractions/32 days with adriamycin administered before, during, and after irradiation. The locally enhancing effects of adriamycin on hepatic tolerance to irradiation are discussed.

Original languageEnglish (US)
Pages (from-to)81-84
Number of pages4
JournalCancer
Volume42
Issue number1
DOIs
StatePublished - Jan 1 1978

Fingerprint

Doxorubicin
Liver

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Hepatopathy following irradiation and adriamycin. / Kun, Larry E.; Camitta, Bruce M.

In: Cancer, Vol. 42, No. 1, 01.01.1978, p. 81-84.

Research output: Contribution to journalArticle

Kun, Larry E. ; Camitta, Bruce M. / Hepatopathy following irradiation and adriamycin. In: Cancer. 1978 ; Vol. 42, No. 1. pp. 81-84.
@article{b7342a90c7ce414097775fbc0c2e09ba,
title = "Hepatopathy following irradiation and adriamycin",
abstract = "This report describes two cases of hepatopathy following irradiation and adriamycin at doses and volumes of irradiation ordinarily considered within the tolerance of hepatic function. In one case fatal hepatopathy followed 2400 rad/17 fractions/28 days to the entire liver with preceding and concurrent adriamycin. In the second case moderate clinical changes occurred after treatment in which much of the right lobe of the liver was shielded following 2500 rad/23 fractions/32 days with adriamycin administered before, during, and after irradiation. The locally enhancing effects of adriamycin on hepatic tolerance to irradiation are discussed.",
author = "Kun, {Larry E.} and Camitta, {Bruce M.}",
year = "1978",
month = "1",
day = "1",
doi = "10.1002/1097-0142(197807)42:1<81::AID-CNCR2820420113>3.0.CO;2-K",
language = "English (US)",
volume = "42",
pages = "81--84",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Hepatopathy following irradiation and adriamycin

AU - Kun, Larry E.

AU - Camitta, Bruce M.

PY - 1978/1/1

Y1 - 1978/1/1

N2 - This report describes two cases of hepatopathy following irradiation and adriamycin at doses and volumes of irradiation ordinarily considered within the tolerance of hepatic function. In one case fatal hepatopathy followed 2400 rad/17 fractions/28 days to the entire liver with preceding and concurrent adriamycin. In the second case moderate clinical changes occurred after treatment in which much of the right lobe of the liver was shielded following 2500 rad/23 fractions/32 days with adriamycin administered before, during, and after irradiation. The locally enhancing effects of adriamycin on hepatic tolerance to irradiation are discussed.

AB - This report describes two cases of hepatopathy following irradiation and adriamycin at doses and volumes of irradiation ordinarily considered within the tolerance of hepatic function. In one case fatal hepatopathy followed 2400 rad/17 fractions/28 days to the entire liver with preceding and concurrent adriamycin. In the second case moderate clinical changes occurred after treatment in which much of the right lobe of the liver was shielded following 2500 rad/23 fractions/32 days with adriamycin administered before, during, and after irradiation. The locally enhancing effects of adriamycin on hepatic tolerance to irradiation are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0018075615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018075615&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(197807)42:1<81::AID-CNCR2820420113>3.0.CO;2-K

DO - 10.1002/1097-0142(197807)42:1<81::AID-CNCR2820420113>3.0.CO;2-K

M3 - Article

C2 - 667811

AN - SCOPUS:0018075615

VL - 42

SP - 81

EP - 84

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 1

ER -